WallStreetZenWallStreetZen

NASDAQ: ASRT
Assertio Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ASRT past earnings growth

How has ASRT's earnings growth performed historically?
Company
266.07%
Industry
63.09%
Market
36.61%
ASRT's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ASRT's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ASRT's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ASRT past revenue growth

How has ASRT's revenue growth performed historically?
Company
28.78%
Industry
11.23%
Market
13.73%
ASRT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ASRT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ASRT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ASRT earnings and revenue history

Current Revenue
$168.0M
Current Earnings
$97.7M
Current Profit Margin
58.2%

ASRT Return on Equity

Current Company
45.2%
Current Industry
11.8%
Current Market
22.1%
ASRT's Return on Equity (45.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ASRT announces earnings.

ASRT Return on Assets

Current Company
25.1%
Current Industry
3.7%
ASRT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ASRT Return on Capital Employed

Current Company
7.66%
Current Industry
6.8%
ASRT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASRT vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ASRT$168.02M$54.39M$97.71M-15.13%+266.07%
OPTN$72.23M-$27.74M-$46.38M+102.17%N/A
ZOM$22.44M-$20.92M-$20.06M+2,634.65%N/A
EBS$1.07B-$343.20M-$608.00M+9.52%N/A
SCYX$135.67M$50.58M$44.37M+250.63%N/A
View Top Pharmaceutical Stocks

ASRT earnings dates

Next earnings date
Nov 6, 2023

Assertio Holdings Earnings & Revenue FAQ

What were ASRT's earnings last quarter?

On Invalid Date, Assertio Holdings (NASDAQ: ASRT) reported Q2 2023 earnings per share (EPS) of $0.15, up 11.76% year over year. Total Assertio Holdings earnings for the quarter were $8.47 million. In the same quarter last year, Assertio Holdings's earnings per share (EPS) was $0.17.

If you're new to stock investing, here's how to buy Assertio Holdings stock.

What was ASRT's earnings growth in the past year?

As of Q3 2023, Assertio Holdings's earnings has grown 266.07% year over year. This is 202.98 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 63.09%. Assertio Holdings's earnings in the past year totalled $97.71 million.

What is ASRT's earnings date?

Assertio Holdings's earnings date is Invalid Date. Add ASRT to your watchlist to be reminded of ASRT's next earnings announcement.

What was ASRT's revenue last quarter?

On Invalid Date, Assertio Holdings (NASDAQ: ASRT) reported Q2 2023 revenue of $40.99 million up 16.68% year over year. In the same quarter last year, Assertio Holdings's revenue was $35.13 million.

What was ASRT's revenue growth in the past year?

As of Q3 2023, Assertio Holdings's revenue has grown 28.78% year over year. This is 17.55 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 11.23%. Assertio Holdings's revenue in the past year totalled $168.02 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.